Please Wait
Applying Filters...
menu
    • menu
    Coral

    Virtual Booth

    Contact Supplier

    China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    Alchem offers Botanical APIs for Pharmaceuticals, Cosmetics and Nutraceuticals// FDA-inspected and EU-GMP certified.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Avacincaptad Pegol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ivervay Shows Higher Chance Of Preserving Driving Eligibility
    Ivervay Shows Higher Chance Of Preserving Driving Eligibility

    12 May 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/izervay-avacincaptad-pegol-intravitreal-solution-demonstrated-increased-probability-of-maintaining-driving-eligibility-in-geographic-atrophy-patients-302768710.html

    PR NEWSWIRE
    12 May 2026
    Share Share
    Astellas Showcases Geographic Atrophy Findings At ARVO 2026
    Astellas Showcases Geographic Atrophy Findings At ARVO 2026

    30 Apr 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/astellas-to-highlight-new-findings-for-geographic-atrophy-at-arvo-2026-annual-meeting-302758002.html

    PR NEWSWIRE
    30 Apr 2026
    Share Share
    Aviceda Announces Phase 2b SIGLEC Results in Geographic Atrophy
    Aviceda Announces Phase 2b SIGLEC Results in Geographic Atrophy

    15 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251215245453/en/Aviceda-Therapeutics-Announces-Phase-2b-SIGLEC-Results-for-AVD-104-in-Geographic-Atrophy

    BUSINESSWIRE
    15 Dec 2025
    Share Share
    Astellas, Grandma Babs Partner to Raise Awareness on GA
    Astellas, Grandma Babs Partner to Raise Awareness on GA

    23 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/astellas-and-the-internets-favorite-grandma-barbara-babs-costello-partner-to-encourage-others-to-get-ahead-of-geographic-atrophy-ga-302591850.html

    PR NEWSWIRE
    23 Oct 2025
    Share Share
    Astellas To Unveil IZERVAY Data In Geographic Atrophy At AAO
    Astellas To Unveil IZERVAY Data In Geographic Atrophy At AAO

    08 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/astellas-to-present-new-data-on-izervay-avacincaptad-pegol-intravitreal-solution-in-geographic-atrophy-at-aao-2025-annual-meeting-302579011.html

    PR NEWSWIRE
    08 Oct 2025
    Share Share
    With Sales Turnaround, Astellas Projects Big Growth for Izervay
    With Sales Turnaround, Astellas Projects Big Growth for Izervay

    10 Jul 2025

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/astellas-reports-22-sales-bump-izervay-projects-trend-continue-year

    FIERCE PHARMA
    10 Jul 2025
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.